Malaria Elimination in South East Asia Region Progress, Challenges and the Way Forward Dr. Deyer Gopinath, WHO / Thailand Dr. Leonard Ortega, WHO / SEARO.

Slides:



Advertisements
Similar presentations
Global Measles and Rubella Strategic Plan
Advertisements

The Work of WHO in the South-East Asia Region Report of the Regional Director 1 July 2008–31 August 2009 Highlights of the Work of in the South-East.
Strategies for Working with Countries – Regional and Sub-Regional Perspective and Experiences Essential Drugs and Medicines Policy WHO South-East Asia.
22-24 November 2011 Community Engagement for Malaria Elimination Workshop Centara Duangtawan Hotel, Chiang Mai, Thailand.
Burden of malaria and other infectious diseases in the Asia-Pacific Ravi P. Rannan-Eliya Institute for Health Policy Sri Lanka.
Regional Situation on ICD Implementation and Related Activities in the South East Asia Region of WHO Jyotsna Chikersal RA-HST, WHO-SEARO WHO-FIC APN Meeting,
AusAID’s approach to health in developing countries
Technical Advisory Group meeting, WHO/WPRO
Regional initiative to sustain country achievement SEAR Krongthong Thimasarn Regional Adviser, Malaria World Health Organization Regional Office for South-
The Work of WHO in the South-East Asia Region The Work of WHO in the South-East Asia Region Biennial Report of the Regional Director 1 January
1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.
HIV/AIDS: A Global and Regional Perspective AIDS in Post 2015 Development Agenda.
Post-MDA surveillance ( including xeno-monitoring) Krishnamoorthy K. Vector Control Research Centre Pondicherry India.
Dr. Nurhayati Ali Assegaf MP, Vice-Chairperson of the Committee for Inter-Parliamentary Cooperation House of Representative of the Republic of Indonesia.
Progress towards Sustainable Measles Mortality Reduction South-East Asia Region Jayantha Liyanage Medical Officer- EPI Immunization and Vaccine Development.
1 1 Measles elimination and rubella control in the SEA Region- a brief Update 12 th Annual Meeting of the Measles Rubella Initiative (MRI) September,
World Health Assembly 63 Geneva, Suisse May 2010 WORLD HEALTH EDITORS NETWORK Tracking Global Health News: building health literacy Multi-Drug Resistant.
African Business Leaders on Health: GBC Conference on TB, HIV-TB Co-infection & Global Fund Partnership Johannesburg, October 11, 2010 The state of Global.
An Overview of TB in SAARC Countries and Role of SAARC TB Centre in TB Control Dr Paras K Pokharel, Associate Professor Dept. of Community Medicine, BPKIHS.
World Bank Seminar Series: Global Issues Facing Humanity Diseases without borders.
Millennium Development Goals Rachel Reyes. Goal one – Eradicate extreme hunger and poverty. The goals of the government to achieve this is to: Halve the.
Containment of artemisinin resistance at the Cambodia-Thailand border Sylvia Meek, Technical Director, Malaria Consortium, CMWG Meeting 8 July 2009.
1 1 Bose: SEAR Highlights and Priorities Global Measles & Rubella Management Meeting Geneva, March 2011 Accelerated Measles Control: Highlights and.
Global burden of LF Around 1.4 billion people in 73 countries at risk Over 120 million infected About 40 million disfigured and incapacitated.
Millennium Development Goals Carla AbouZahr Coordinator, Statistics, Monitoring and Analysis Department of Health Statistics and Informatics World Health.
Securing the future today Synthesis of strategic information on HIV and young people Global Interagency Task Team on HIV and young people, June 2011.
Malaria Eradication: Ethics, Autonomy, Priorities David Brandling-Bennett Deputy Director, Malaria Infectious Diseases, Global Health Program May 3, 2011.
EGM on International Standards for Civil Registration and Vital Statistics Systems June 2011, New York Towards a regional programme for the improvement.
Learning Unit 7 Health systems and inter-sectoral and cross-border collaboration 14 August 2014 Part 1 Dr. Leonard I. Ortega Regional Adviser, Malaria.
Learning Unit 7 Health systems and inter-sectoral and cross-border collaboration 14 Feb 2014 Dr. Leonard I. Ortega Regional Adviser, Malaria WHO-SEARO.
ASDPE International Health Regulations (IHR 2005) Laboratory and Zoonosis update Dr Richard Brown, WHO Thailand Workshop on Laboratory Diagnosis for Zoonotic.
National Influenza Centres in SEA Region Dr Rajesh Bhatia / Dr Oommen John WHO Regional Office for South-East Asia New Delhi 5 th Meeting of NIC in Western.
Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.
A global partnership to stop measles & rubella 1 Measles & Rubella Initiative --Who We Are-- Stephen Cochi, MD, MPH Global Immunization Division Centers.
Malaria a story of ELIMINATION A partnership of:.
HIV and AIDS Data Hub for Asia-Pacific 1 Review in slides Women, Children, and Young People HIV and AIDS Data Hub for Asia-Pacific.
2007 Pan American Health Organization 2004 Pan American Health Organization Malaria in the Americas: Progress, Challenges, Strategies and Main Activities.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Rabies – One Health Model disease Outcome of Group work Regional Training in Animal and Human Health Epidemiology in South Asia.
WHO Global Health Sector Strategies HIV; Viral Hepatitis; Sexually Transmitted Infections Common structure Universal Health Coverage SDGs Cascade.
President’s Malaria Initiative: Presentation of PMI Progress, Strategy, and Priorities: RBM CCOP Meeting September 29, 2015.
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
World Health Organization
Study of Trends in South Asia:
Seasonal Malaria Chemoprevention: WHO Policy and Perspectives
Ladies and gentlemen, On behalf of my country, the Republic of Côte d’Ivoire, I want to tell you how very pleased I am to be part of this high-level meeting,
Malaria Elimination Programme Timor Leste
Global Overview of Measles
Zimbabwe’s shift towards treat all: national country context
financial requirements
Tailored Review Proposal for Tuberculosis
POLIOPLUS FACT SHEET Feb 2018
Progress: Bangladesh CCM GF SEA Constituency Meeting New Delhi, India
Pre-conference Meeting Report
Neglected Tropical Diseases Hidden and silent : Key problems
Young People (15-24 year) Last updated: April 2018.
Key issues in DOTS implementation
By: Dr Mirzaei.
Update on HIV and TB situation in SEAR Dr Mukta Sharma RA HIV TB HEP WHO SEARO Global Fund , South-East Asia Constituency Meeting, April 2018,
Petchsri Sirinirund Advisor to HIV/AIDS Policy and Programme
Neglected Tropical Diseases Hidden and silent : Key problems
State of Measles Initiative Financing Partners for Measles Advocacy Meeting Washington, D.C. September 22, 2008 Andrea Gay.
The STOP TB Strategy – 2009 VISION: A TB-free world
A Time of Commitments and Actions to accelerate action to End TB
Data Availability Last updated: April 2019.
Dte. National Vector Borne Diseases Control Programme (NVBDCP), MOHFW
An Enabling Business Environment and A Strategic Collaborative Approach for Sustainable Quality Local Production Africa Pharma Conference 4-5 June 2019,
Len Tarivonda, Director of Public Health Ministry of Health
Malaria – amazing success; huge challenges
Global status report on road safety 2018
Presentation transcript:

Malaria Elimination in South East Asia Region Progress, Challenges and the Way Forward Dr. Deyer Gopinath, WHO / Thailand Dr. Leonard Ortega, WHO / SEARO

Contents Malaria situation: global and regional Malaria goals and targets: post 2015 Strategies Key challenges Opportunities The way forward

Global Malaria Situation (1) Change in malaria mortality rate estimated malaria deaths: deaths (uncertainty range: – ) 90% of all malaria deaths occurred in WHO African Region, mainly in children aged under 5 years, who account for 78% of all malaria deaths globally between 2000 and 2013: 4.3 million deaths averted [Reference: World Malaria Report 2014]

Global Malaria Situation (2) Trends in reported cases of malaria 64 out of 106 countries with malaria in 2000 are meeting the MDG target of reversing the incidence of malaria 55 are on track to meet RBM and WHA targets of reducing incidence rates by 75% by 2015 Estimated cases in 2013: 198 million cases

Regional Malaria Situation Ten of 11 Member States in WHO South East Asia Region are endemic to malaria. Around 1.1 billion population at risk of malaria. High risk groups are mainly the mobile and migrant populations engaged in various economic activities in rural areas in the region, in hard to reach areas, tribal communities and along the borders where access to health services is a challenge.

Global Technical Strategy for Malaria Endorsed by WHA in May 2015, joint GTS/AIM launch at 3 rd Intl Conference on Financing for Development - Addis Ababa, July 2015 Global goal for 2030: A world free of malaria 1.Reduce malaria mortality rates globally by at least 90% compared with Reduce malaria case incidence globally by at least 90% compared with Eliminate malaria from at least 35 countries in which malaria was transmitted in Prevent re-establishment of malaria in all countries that are malaria-free

Regional Strategic Objectives vs. Global Technical Strategy Regional Strategic Objectives Generate strategic information 2.Scale-up key interventions in countries and areas with high burden of malaria 3.Reorient national malaria control programmes towards pre- elimination/elimination in countries with very low burden of malaria 4.Prevent the emergence of artemisinin resistance, and eliminate it in areas where it has already emerged 5.Strengthen managerial and technical capacities 6.Strengthen partnerships, multi- sectoral participation and international collaboration

Regional Plans in development o GMS strategy – May 2015 launch o AFRO – Sep 2015 consultation o SEARO – Oct 2015 draft o PAHO – Oct 2015 consultation o EMRO – Oct 2015 regional committee o WPRO – Dec 2015 consultation o EURO – Sep 2016

Regional Malaria Situation (1) Success story in India Annual Parasite Incidence, 2000Annual Parasite Incidence, 2014 Around 55% of the total malaria incidence in the South East Asia Region. In the last 10 years: reported malaria cases declined by 42% from 1.9 million to 1.1 million in 2014, and malaria related deaths was reduced by 41% from 949 in 2004 to 562 in The number of districts with API less than or equal to one has increased from 370 in 2000 to 527 in 2014 (total districts currently: 620)

Malaria Elimination in Indonesia Indonesia: 152 million at risk, 252,027 cases confirmed in 2014; down from 417,819 in 2012; sub-national malaria elimination progressing well (225 out of 511 districts declared malaria free)

Myanmar: 67% reduction of cases (622,373 in 2005; 205,658 in 2014); 95% reduction of deaths (1,707 in 2005; 92 in 2014) 70-80% burden in GMS, 32 million population at risk, 300,000+ cases in 2013

Malaria incidence in Sri Lanka, (Oct 2015) Sri Lanka: reduced cases from 210,000 in 2000 to zero 2013

Regional Malaria Situation Success stories Maldives: first country to elimination malaria (last indigenous case: 1984) Bhutan: reduces cases from more than 5000 in 2000 to only 11 indigenous cases in 2014 DPR Korea: reduced cases by 91% from 115,615 in 2001 to only 10,535 in 2014; no malaria death Timor Leste: cases decreased from 223,002 in 2006 to 1,040 cases in 2013 Thailand: cases decreased from 64,957 in 2010 to 37,680 in 2014 with deaths reduced from 80 to 37.

Malaria Elimination in SEARO CountryTarget year for elimination and remarks 1. Bangladesh2020; not feasible; Malaria National Strategic Plan (NSP) will be revised 2. Bhutan 2018; feasible; cross-border collaboration with India being strengthened; 11 indigenous case in DPRK 2025; 10,535 cases reported in 2014; intensive operations needed to reach elimination goal by India 527 districts with API less then 1/1,000; pre-elimination phase in the whole country by 2017; elimination by 2030; elimination plan to be launched in Feb Indonesia 2030; subnational elimination on track; 225 districts already declared malaria free 6. Myanmar2030; significant progress; NSP being updated 7. Nepal2026; feasible; it could be achieved earlier than Sri Lankazero indigenous case since Oct 2012; certification being planned in Timor Leste elimination goal agreed but target year not yet decided; marked reduction of cases from 223,002 in 2006 to 1,040 in Thailand2024; feasible; program review done recently; NSP being updated

Key Challenges The long-term usefulness of ACTs is threatened by the emergence or spread of resistance to artemisinin Drug resistance Infectious reservoir Outdoor biting vectors Health system Insecticide resistance P. vivax Unregulated private sector Financial resources The greatest threat to continued success in malaria efforts is financial Millions of people with undetected malaria infection represent a large reservoir of parasites that can fuel transmission Pyrethroids are key to vector control but resistance is widespread P. vivax poses numerous unique diagnostic and therapeutic challenges that disproportionately affect vulnerable groups These mosquitoes are not targeted by core vector control methods and pose a challenge for prevention of transmission Many people seek treatment in the private sector where there is poor regulation of diagnostic and therapeutic practices Shortages of human and material resources and poor infra- structure adversely affect case management, vector control & surveillance

Opportunities (1): strong political support and global interest

Opportunities (2): tools and innovations Diagnostics – Rapid diagnostic test for malaria – Rapid diagnostic test for GPD deficiency – PCR (for field use) Drugs – On going research on new molecules – Tafenoquine (for radical cure; single dose) Vaccine Research on prevention of outdoor transmission Mass drug administration Information technology for surveillance Tool kit for malaria control among mobile and migrant populations Community-based interventions Plasmodium vivax control and elimination: a technical brief

The way forward (2) Innovative and sustainable financing Efficient and effective utilization of resources Invest in health system strengthening Multisectoral engagement Cross-border / inter-country collaboration